Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v7-EN
Language French English
Date Updated 2017-08-30 2017-07-19
Drug Identification Number 02379422 02379422
Brand name TOPOTECAN HYDROCHLORIDE FOR INJECTION TOPOTECAN HYDROCHLORIDE FOR INJECTION
Common or Proper name Topotecan Topotecan
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients TOPOTECAN TOPOTECAN
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5 x 4mL 5 x 4mL
ATC code L01XX L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2017-07-12 2017-07-12
Actual start date
Estimated end date 2017-08-30 2017-08-28
Actual end date 2017-08-29
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Resolved August 29, 2017
Health Canada comments